Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
QuintilesIMS
Argus Health
Merck
Mallinckrodt
Moodys
Fuji
Daiichi Sankyo
Fish and Richardson
Dow

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020222

« Back to Dashboard

NDA 020222 describes COLESTID, which is a drug marketed by Pharmacia Upjohn and is included in two NDAs. It is available from five suppliers. Additional details are available on the COLESTID profile page.

The generic ingredient in COLESTID is colestipol hydrochloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.
Summary for 020222
Tradename:COLESTID
Applicant:Pharmacia Upjohn
Ingredient:colestipol hydrochloride
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020222
Mechanism of ActionBile-acid Binding Activity
Medical Subject Heading (MeSH) Categories for 020222
Suppliers and Packaging for NDA: 020222
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
COLESTID colestipol hydrochloride TABLET;ORAL 020222 NDA Pharmacia and Upjohn Company LLC 0009-0450 N 0009-0450-03
COLESTID colestipol hydrochloride TABLET;ORAL 020222 NDA AUTHORIZED GENERIC Physicians Total Care, Inc. 54868-0610 E 54868-0610-1

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1GM
Approval Date:Jul 19, 1994TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Medtronic
US Department of Justice
Daiichi Sankyo
Deloitte
Cantor Fitzgerald
Boehringer Ingelheim
Moodys
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot